WallStSmart

Churchill Capital Corp XI (CCXI)vsSilver Pegasus Acquisition Corp. (SPEG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

SPEG leads profitability with a 0.0% profit margin vs 0.0%. SPEG earns a higher WallStSmart Score of 30/100 (F).

CCXI

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 5.0Quality: 4.0
Piotroski: 2/9

SPEG

Avoid

30

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 4.0Quality: 5.0
Piotroski: 3/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

SPEG0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$746.38M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

SPEG4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$158.70M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : SPEG

SPEG has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : SPEG

The primary concerns for SPEG are Revenue Growth, EPS Growth, Market Cap. A P/E of 172.5x leaves little room for execution misses.

Key Dynamics to Monitor

SPEG is growing revenue faster at 0.0% — sustainability is the question.

SPEG generates stronger free cash flow (-77,530), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SPEG scores higher overall (30/100 vs 23/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Silver Pegasus Acquisition Corp.

FINANCIAL SERVICES · SHELL COMPANIES · USA

Silver Pegasus Acquisition Corp. The company is headquartered in Santa Clara, California.

Want to dig deeper into these stocks?